Tiziana Lifesciences Announces Intention to Demerge Its StemPrintER Genomics-Based Personalized Medicine Business as a Separate Listed Company
Stock Information for Eton Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.